To recover your password please fill in your email address
Please fill in below form to create an account with us
Title: Single arm, open label signal seeking, phase II trial to study the clinical activity of Tildrakizumab in patients with advanced osteosarcoma and soft tissue sarcomas.
|
Trial Summary: |
The aim of these MoST substudies is to assess the clinical activity of tildrakizumab in patients with advanced osteosarcomas or soft tissue sarcomas. |
|
Supported By: |
|
|
Eligibility: |
Treatment-refractory advanced osteosarcoma and other sarcomas. |
|
Registration ID: |
ACTRN12620000984998 |
|
Participation: |
National |
|
Status: |
In follow-up |
|
Activation Date: |
09/03/2021 |
|
Chairs: |
Prof David Thomas |
|
Contact: |